Age and location in severity of COVID‐19 pathology: Do lactoferrin and pneumococcal vaccination explain low infant mortality and regional differences?

R Root‐Bernstein - BioEssays, 2020 - Wiley Online Library
Two conundrums puzzle COVID‐19 investigators: 1) morbidity and mortality is rare among
infants and young children and 2) rates of morbidity and mortality exhibit large variances …

[HTML][HTML] Pneumonia and invasive pneumococcal diseases: the role of pneumococcal conjugate vaccine in the era of multi-drug resistance

C Scelfo, F Menzella, M Fontana, G Ghidoni… - Vaccines, 2021 - mdpi.com
Streptococcus pneumoniae related diseases are a leading cause of morbidity and mortality,
especially in children and in the elderly population. It is transmitted to other individuals …

Vaccines for older adults

AL Cunningham, P McIntyre, K Subbarao, R Booy… - bmj, 2021 - bmj.com
The proportion of the global population aged 65 and older is rapidly increasing. Infections in
this age group, most recently with SARS-CoV-2, cause substantial morbidity and mortality …

[HTML][HTML] Pathogen-and type-specific changes in invasive bacterial disease epidemiology during the first year of the COVID-19 pandemic in the Netherlands

A Steens, MJ Knol, W Freudenburg-de Graaf… - Microorganisms, 2022 - mdpi.com
COVID-19 control measures have resulted in a decline in invasive bacterial disease caused
by Neisseria meningitidis (IMD), Streptococcus pneumoniae (IPD), and Haemophilus …

Validation of Fourier transform infrared spectroscopy for serotyping of Streptococcus pneumoniae

I Passaris, N Mauder, M Kostrzewa… - Journal of clinical …, 2022 - Am Soc Microbiol
Fourier transform infrared (FT-IR) spectroscopy (IR Biotyper; Bruker) allows highly
discriminatory fingerprinting of closely related bacterial strains. In this study, FT-IR …

Dynamics of antimicrobial resistance of Streptococcus pneumoniae following PCV10 introduction in Brazil: Nationwide surveillance from 2007 to 2019

MCC Brandileone, SCG Almeida, S Bokermann… - Vaccine, 2021 - Elsevier
Background Brazil introduced 10-valent pneumococcal conjugate vaccine (PCV10) into its
immunization program in 2010. We assessed antimicrobial susceptibility of Streptococcus …

Time for a third-generation pneumococcal conjugate vaccine

KP Klugman, GL Rodgers - The Lancet Infectious Diseases, 2021 - thelancet.com
In The Lancet Infectious Diseases, Naim Ouldali and colleagues1 describe the effect of
pneumococcal conjugate vaccines (PCVs) on the incidence of invasive pneumococcal …

[HTML][HTML] The burden of invasive meningococcal disease in the Netherlands, 2011–2020

M Middeldorp, A Steens, G Lagerweij, NM van Sorge… - Vaccine, 2023 - Elsevier
Introduction Representative information on disease course and outcome of invasive
meningococcal disease (IMD) is important because of the shift in meningococcal …

[HTML][HTML] Systematic review on the impact of the pneumococcal conjugate vaccine ten valent (PCV10) or thirteen valent (PCV13) on all-cause, radiologically confirmed …

R Reyburn, A Tsatsaronis, C von Mollendorf… - Journal of Global …, 2023 - ncbi.nlm.nih.gov
Background There is an ongoing need to assess the impact of pneumococcal conjugate
vaccines (PCVs) to guide the use of these potentially valuable but under-utilized vaccines …

[HTML][HTML] Assessing Public Health Impact of Four Pediatric Pneumococcal Conjugate Vaccination Strategies in the Netherlands

M Wilson, C McDade, AT Beby-Heijtel… - Infectious Diseases and …, 2023 - Springer
Introduction The 10-valent pneumococcal conjugate vaccine (PCV10, Synflorix) was
introduced into the Dutch pediatric national immunization program (NIP) starting in 2011 …